However, our results demonstrate that the investigated breast cancer samples express at least two members of the CYP family, raising the possibility that CYP3A4- and CYP2C9-catalysed metabolism in tumour tissue could result in local bioactivation and/or deactivating N-dechloroethylation of ifosfamide. This evidence concerns the gene CYP2C9 and breast carcinoma.